ADMA Biologics (NASDAQ:ADMA) reported its Q1 earnings results on Wednesday, May 10, 2023 at 04:05 PM.
Here’s what investors need to know about the announcement.
Earnings
ADMA Biologics beat estimated earnings by 25.0%, reporting an EPS of $-0.03 versus an estimate of $-0.04.
Revenue was up $27.81 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.0 which was followed by a 6.75% increase in the share price the next day.
Here’s a look at ADMA Biologics’s past performance:
| Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.06 | -0.08 | -0.08 | -0.08 |
| EPS Actual | -0.06 | -0.08 | -0.07 | -0.10 |
| Revenue Estimate | 45.93M | 34.48M | 31.81M | 27.69M |
| Revenue Actual | 49.98M | 41.09M | 33.91M | 29.10M |
To track all earnings releases for ADMA Biologics visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
